Search Clinical Pathways
Multisystem Inflammatory Syndrome (MIS-C) Clinical Pathway — Emergency, ICU and Inpatient
Multisystem Inflammatory Syndrome (MIS-C), ED, ICU and Inpatient
Pancreatitis Clinical Pathway — Emergency Department and Inpatient
This pathway should be used to guide the screening, assessment, and care planning for patients with known or suspected non-traumatic pancreatitis in an emergency or inpatient setting.
Sickle Cell and Acute Chest Syndrome Clinical Pathway — Inpatient
Treatment for the hospitalized Sickle Cell patient with Acute Chest Syndrome.
Bronchiolitis Clinical Pathway — Inpatient
The bronchiolitis pathway details the steps necessary in the assessment and treatment of a child with bronchiolitis in an inpatient setting.
Nutrition Initiation and Advancement Clinical Pathway — PICU/PCU
The PICU Inpatient Pathway for Initiation and Advancement of Nutrition clinical pathway is intended to guide providers in the basic initiation and advancement of enteral nutrition in the critically ill pediatric intensive care unit patient.
Inhaled Nitric Oxide for Persistent Pulmonary Hypertension Clinical Pathway — N/IICU
The inhaled nitric oxide pathway takes a step-by-step approach to the initiation and management of nitric oxide in newborns with persistent pulmonary hypertension.
Nutrition for Neonates with Congenital Heart Disease Clinical Pathway — CICU
The Nutrition for Neonates Undergoing Surgery for Congenital Heart Disease Clinical Pathway outlines the recommended approach to nutrition management for neonates undergoing cardiac surgery in the first 30 days of life.
COVID-19 Screening Clinical Pathway — Outpatient Specialty Care and Primary Care
The Outpatient Specialty Care and Primary Care Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.
COVID-19 Screening Clinical Pathway — Emergency
The ED Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.
Active COVID-19, Clinical Pathway — All Settings
Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.